Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04506853 · ClinicalTrials.gov registry record · NA

Single-Sided Deafness and Asymmetric Hearing Loss

A NA study of Hearing Loss, Sensorineural and Hearing Loss, Unilateral, sponsored by Med-El Corporation.

Recruiting
Registry status
NA
Development phase
65
Enrollment target
6
Study locations

NCT04506853 is a NA study of Hearing Loss, Sensorineural and Hearing Loss, Unilateral that is actively recruiting participants, run by Med-El Corporation. The registered enrollment target is 65 participants, below the 783-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (92% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04506853, a NA study of Hearing Loss, Sensorineural and Hearing Loss, Unilateral, is actively recruiting participants, sponsored by Med-El Corporation.

RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
6
Study locations

Study Summary

The purpose of the study is to evaluate the long-term safety and effectiveness of cochlear implantation of the approved population in adults and children with single-sided deafness and asymmetric hearing loss.

Interventions

  • DEVICE MED-EL Cochlear Implant System

Study Locations (6)

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Iowa

  • University of Iowa - Iowa City

New York

  • New York Eye and Ear Infirmary - New York

North Carolina

  • University of North Carolina - Chapel Hill

Washington

  • Virginia Mason Medical Center - Seattle

Ontario

  • Sunnybrook Health Sciences Center - Toronto

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2021-02-22
Est. Completion 2026-12
Phase NA

Sponsor

Med-El Corporation

14 total trials

What the Registry Record Tells You About NCT04506853

The ClinicalTrials.gov registry entry for NCT04506853 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 783-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (92% lower). The listed sponsor is Med-El Corporation, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which MED-EL Cochlear Implant System is the first listed.

NCT04506853 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Illinois, Iowa, New York.

Frequently Asked Questions

What is clinical trial NCT04506853 about?

NCT04506853 is a clinical study titled "Single-Sided Deafness and Asymmetric Hearing Loss". The purpose of the study is to evaluate the long-term safety and effectiveness of cochlear implantation of the approved population in adults and children with single-sided deafness and asymmetric hearing loss.

What is the current status of trial NCT04506853?

This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2021-02-22. Estimated completion is 2026-12.

What conditions does trial NCT04506853 study?

This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Hearing Loss, Unilateral.

What interventions are being tested in trial NCT04506853?

The interventions under investigation include: MED-EL Cochlear Implant System (DEVICE).

Who is sponsoring clinical trial NCT04506853?

This trial is sponsored by Med-El Corporation, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04506853 being conducted?

This trial has 6 study locations across Illinois, Iowa, New York, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Sensorineural

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.